EMEA-002707-PIP01-19-M02 - paediatric investigation plan
doravirine
Islatravir
PIPHuman
Key facts
- Active Substance
- doravirine
- Islatravir
- Therapeutic area
- Infections and infestations
- Decision number
- P/0268/2024
- PIP number
- EMEA-002707-PIP01-19-M02
- Pharmaceutical form(s)
- Age appropriate oral solid dosage form
- Tablet
- Condition(s) / indication(s)
- Treatment of human immunodeficiency virus (HIV-1) infection
- Route(s) of administration
- Oral use
- Contact for public enquiries
Merck Sharp & Dohme (Europe) Inc.
Tel.: +33180464738
E-mail: pip.information@merck.com- Decision type
- PM: decision on the application for modification of an agreed PIP
- Decision date